Efficacy and safety of rituximab for minors with immune thrombocytopenia: a systematic review and meta-analysis

OBJECTIVE: We reviewed relevant research on rituximab (RTX) treatment for pediatric immune thrombocytopenia (ITP) to elucidate the efficacy and safety of RTX. METHODS: Prospective clinical trials of RTX for the treatment of pediatric ITP were collected by searching the PubMed, Cochrane Library, Web...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Min, Zhou, Jing, Yang, Song-Jun, Zhou, Ze-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645434/
https://www.ncbi.nlm.nih.gov/pubmed/33115308
http://dx.doi.org/10.1177/0300060520962348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645434/
https://www.ncbi.nlm.nih.gov/pubmed/33115308
http://dx.doi.org/10.1177/0300060520962348

Ejemplares similares